Huanglian-Renshen-Decoction Maintains Islet β-Cell Identity in T2DM Mice through Regulating GLP-1 and GLP-1R in Both Islet and Intestine
Chinese Journal of Integrative Medicine · 2025
DOI: 10.1007/s11655-024-3915-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Integrative Medicine, 2025. Verfasst von Wen-Bin Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institution of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Techn…. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor, Insulin-Secreting Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To elucidate the effect of Huanglian-Renshen-Decoction (HRD) on ameliorating type 2 diabetes mellitus by maintaining islet β -cell identity through regulating paracrine and endocrine glucagon-like peptide-1 (GLP-1)/GLP-1 receptor (GLP-1R) in both islet and intestine. METHODS: The db/db mice were divided into the model (distilled water), low-dose HRD (LHRD, 3 g/kg), high-dose HRD (HHRD, 6 g/kg), and liraglutide (400 µ g/kg) groups using a random number table, 8 mice in each group. The db/m mice were used as the control group (n=8, distilled water). The entire treatment of mice lasted for 6 weeks. Blood insulin, glucose, and GLP-1 levels were quantified using enzyme-linked immunosorbent assay kits. The proliferation and apoptosis factors of islet cells were determined by immunohistochemistry (IHC) and immunofluorescence (IF) staining. Then, GLP-1, GLP-1R, prohormone convertase 1/3 (PC1/3), PC2, v-maf musculoaponeurotic fibrosarcoma oncogene homologue A (MafA), and pancreatic and duodenal homeobox 1 (PDX1) were detected by Western blot, IHC, IF, and real-time quantitative polymerase chain reaction, respectively. RESULTS: HRD reduced the weight and blood glucose of the db/db mice, and improved insulin sensitivity at the same time (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institution of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
- Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
- Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. echo_yf@tjh.tjmu.edu.cn.
Zitieren
APA
Wu, W. B., Gao, F., Tang, Y. H., Wang, H. Z., Dong, H., Lu, F. E., & Yuan, F. (2025). Huanglian-Renshen-Decoction Maintains Islet β-Cell Identity in T2DM Mice through Regulating GLP-1 and GLP-1R in Both Islet and Intestine. Chinese Journal of Integrative Medicine. https://doi.org/10.1007/s11655-024-3915-1
Vancouver
Wu WB, Gao F, Tang YH, Wang HZ, Dong H, Lu FE, et al. Huanglian-Renshen-Decoction Maintains Islet β-Cell Identity in T2DM Mice through Regulating GLP-1 and GLP-1R in Both Islet and Intestine. Chinese Journal of Integrative Medicine. 2025. doi:10.1007/s11655-024-3915-1
BibTeX
@article{Wu2025,
author = {Wu, Wen-Bin and Gao, Fan and Tang, Yue-Heng and Wang, Hong-Zhan and Dong, Hui and Lu, Fu-Er and Yuan, Fen},
title = {Huanglian-Renshen-Decoction Maintains Islet β-Cell Identity in T2DM Mice through Regulating GLP-1 and GLP-1R in Both Islet and Intestine},
journal = {Chinese Journal of Integrative Medicine},
year = {2025},
doi = {10.1007/s11655-024-3915-1}
}
EUVIMED